Thursday, April 25, 2013
Drug compounding supplier Arseus buys U.S.-based Freedom Pharma
The acquisition strengthens its global position in the market for drug compounding, where pharmacists assemble medicines themselves specifically tailored to the needs of their customers.
Arseus said in a statement that it paid 5.5 times EBITDA for FreedomPharmaceuticals, which expects to achieve turnover of about $25 million in 2013.
Source found here